These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3886025)
21. Intravenous naloxone administration in schizophrenia and affective illness. Davis GC; Bunney WE; DeFraites EG; Kleinman JE; van Kammen DP; Post RM; Wyatt RJ Science; 1977 Jul; 197(4298):74-7. PubMed ID: 325650 [TBL] [Abstract][Full Text] [Related]
22. Lack of effect on naloxone on schizophrenic symptoms. Janowsky DS; Segal DS; Bloom F; Abrams A; Guillemin R Am J Psychiatry; 1977 Aug; 134(8):926-7. PubMed ID: 879360 [No Abstract] [Full Text] [Related]
23. Treatment of schizophrenia with a vasopressin analogue. Iager AC; Kirch DG; Bigelow LB; Karson CN Am J Psychiatry; 1986 Mar; 143(3):375-7. PubMed ID: 3513631 [TBL] [Abstract][Full Text] [Related]
24. A high-dose, double-blind study of ceruletide in the treatment of schizophrenia. Mattes JA; Hom W; Rochford JM Am J Psychiatry; 1985 Dec; 142(12):1482-4. PubMed ID: 3907376 [TBL] [Abstract][Full Text] [Related]
25. A study of naloxone with schizophrenic and manic patients. Sethi BB; Prakash R Br J Psychiatry; 1981 Jun; 138():501-3. PubMed ID: 7028200 [TBL] [Abstract][Full Text] [Related]
26. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy. Wilson LG; Roberts RW; Gerber CJ; Johnson MH J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441 [TBL] [Abstract][Full Text] [Related]
27. Hydergine for schizophrenia. Cohen MR; Pary R; Burns R J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983 [No Abstract] [Full Text] [Related]
28. Early antipsychotic response to resumption of neuroleptics in drug-free chronic schizophrenic patients. Glovinsky D; Kirch DG; Wyatt RJ Biol Psychiatry; 1992 May; 31(9):968-70. PubMed ID: 1637936 [No Abstract] [Full Text] [Related]
29. [Administration of naloxone in schizophrenic psychoses and manic syndromes]. Verhoeven WM; van Praag HM; de Jong JT Ned Tijdschr Geneeskd; 1981 Apr; 125(14):532-7. PubMed ID: 6112715 [No Abstract] [Full Text] [Related]
30. Clinical studies on the role of endorphins in schizophrenia. Berger PA; Watson SJ; Akil H; Barchas JD Mod Probl Pharmacopsychiatry; 1981; 17():226-35. PubMed ID: 6276727 [No Abstract] [Full Text] [Related]
31. No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study. Lotstra F; Verbanck P; Mendlewicz J; Vanderhaeghen JJ Biol Psychiatry; 1984 Jun; 19(6):877-82. PubMed ID: 6378259 [No Abstract] [Full Text] [Related]
32. Lack of effect of naloxone and schizophrenic auditory hallucinations. Freeman CP; Fairburn CG Psychol Med; 1981 May; 11(2):405-7. PubMed ID: 7022531 [No Abstract] [Full Text] [Related]
33. Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia. McClelland HA; Farquharson RG; Leyburn P; Furness JA; Schiff AA Arch Gen Psychiatry; 1976 Dec; 33(12):1435-9. PubMed ID: 11760 [TBL] [Abstract][Full Text] [Related]
34. Some effects of piracetam (UCB 6215, Nootropyl) on chronic schizophrenia. Dimond SJ; Scammell RE; Pryce IG; Huws D; Gray C Psychopharmacology (Berl); 1979 Sep; 64(3):341-8. PubMed ID: 116278 [TBL] [Abstract][Full Text] [Related]
35. Naloxone in schizophrenia. Skrabanek P Lancet; 1982 Dec; 2(8310):1270. PubMed ID: 6128561 [No Abstract] [Full Text] [Related]
36. The effects of ceruletide in schizophrenia. Hommer DW; Pickar D; Roy A; Ninan P; Boronow J; Paul SM Arch Gen Psychiatry; 1984 Jun; 41(6):617-9. PubMed ID: 6329121 [TBL] [Abstract][Full Text] [Related]
37. Stability of neurological signs with clozapine treatment. Buchanan RW; Koeppl P; Breier A Biol Psychiatry; 1994 Aug; 36(3):198-200. PubMed ID: 7948457 [No Abstract] [Full Text] [Related]